Israel, Thailand Team on Cancer

Haifa's Rambam Hospital will sign a joint cancer treatment deal Sunday with a Thai research institute.

Hana Levi Julian, MSW, LCSW-R , | updated: 12:06 PM

Thai Princess Chulabhorn, president of CRI
Thai Princess Chulabhorn, president of CRI
Israel news photo: Government of Thailand

It's a small planet.

Global networking is especially helpful when it comes to searching for solutions to life-threatening situations. Medical institutions in particular are aware of that; hence the agreement to be signed Sunday between Rambam Medical Center and Thailand's Chulabhorn Research Institute (CRI).

The two facilities will cooperate on treatment for cancer.

Israeli hospitals are at the cutting edge of providing treatment for cancer, according to the chief of the Department of Oncology at Rambam, Professor Avraham Katan.

The hospital has a worldwide reputation in the treatment of a number of different types of cancers.

Attending the signing ceremony, to be held in Haifa, is the president of CRI, Her Royal Highness Princess Chulabhron Mahidol – the daughter of Thailand's King Bhumibol Adulyadej and Queen Sirikit.

Princess Chulabhorn received her doctorate in Science from Mahidol University in 1985 and has long been involved in the promotion of scientific research. She held the position of guest lecturer at the university and was awarded to UNESCO Einstein Medal in 1986 for promotion of scientific collaboration.

The princess was the first Asian to be invited to join the Royal Society of Chemistry in England as an Honorary Fellow, and holds a a specialization in epileptology.